State Of Wyoming Dynavax Technologies Corp Transaction History

State Of Wyoming

$592 Million
Q2 2024

A detailed history of State Of Wyoming transactions in Dynavax Technologies Corp stock. As of the latest transaction made, State Of Wyoming holds 7,031 shares of DVAX stock, worth $78,325. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,031

Previous 13,523 48.01%

Holding current value

$78,325

Previous $167,000 53.29%

% of portfolio

0.01%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.73 - $12.58 $69,659 - $81,669	-6,492 Reduced 48.01%	7,031 $78,000
Q1 2024 May 13, 2024	BUY	$11.7 - $14.98 $3,896 - $4,988	333 Added 2.52%	13,523 $167,000
Q4 2023 Feb 14, 2024	BUY	$13.09 - $14.98 $107,403 - $122,910	8,205 Added 164.59%	13,190 $184,000
Q3 2023 Nov 14, 2023	SELL	$12.64 - $14.99 $171,941 - $203,908	-13,603 Reduced 73.18%	4,985 $73,000
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.17 $78,248 - $104,622	7,944 Added 74.63%	18,588 $240,000
Q1 2023 May 12, 2023	SELL	$9.44 - $11.88 $87,546 - $110,175	-9,274 Reduced 46.56%	10,644 $104,000
Q4 2022 Feb 14, 2023	BUY	$10.27 - $13.29 $123,352 - $159,626	12,011 Added 151.9%	19,918 $211,000
Q3 2022 Nov 14, 2022	SELL	$9.93 - $17.44 $14,914 - $26,194	-1,502 Reduced 15.96%	7,907 $83,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $12.83 $15,384 - $26,493	2,065 Added 28.12%	9,409 $118,000
Q1 2022 May 13, 2022	BUY	$9.75 - $14.44 $52,133 - $77,210	5,347 Added 267.75%	7,344 $80,000
Q4 2021 Feb 11, 2022	BUY	$13.17 - $20.94 $22,744 - $36,163	1,727 Added 639.63%	1,997 $28,000
Q2 2021 Feb 11, 2022	BUY	$7.25 - $10.99 $891 - $1,351	123 Added 83.67%	270 $3,000
Q1 2021 Feb 08, 2022	BUY	$4.57 - $11.18 $671 - $1,643	147 New	147 $1,000

Others Institutions Holding DVAX

# of Institutions

259

Shares Held

132M

Call Options Held

371K

Put Options Held

99.2K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.41B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.

Account